ASRT
Assertio Holdings, Inc.NASDAQHealthcare$19.21+0.26%ClosedMarket Cap: $123.8M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.32
P/S
1.05
EV/EBITDA
11.97
DCF Value
$99.57
FCF Yield
-22.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
70.2%
Operating Margin
-16.0%
Net Margin
-24.9%
ROE
-29.4%
ROA
-11.1%
ROIC
-13.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $13.5M | 75.9% | $-9.1M | $-11.1M | $-1.86 | — |
| FY 2025 | $118.7M | 70.2% | $-21.5M | $-29.5M | $-4.74 | — |
| Q3 2025 | $49.5M | 72.4% | $11.5M | $11.4M | $1.65 | — |
| Q2 2025 | $29.2M | 63.5% | $-8.0M | $-16.4M | $-2.55 | — |
| Q1 2025 | $26.5M | 70.6% | $-13.2M | $-13.5M | $-2.10 | — |
| Q4 2024 | $32.2M | 63.9% | $-13.5M | $-10.5M | $-1.65 | — |
| FY 2024 | $125.0M | 68.6% | $-24.5M | $-21.6M | $-3.45 | — |
| Q3 2024 | $29.2M | 74.1% | $-3.0M | $-2.9M | $-0.45 | — |
| Q2 2024 | $31.1M | 71.4% | $-3.6M | $-3.7M | $-0.58 | — |
| Q1 2024 | $32.4M | 65.6% | $-4.3M | $-4.5M | $-0.75 | — |
| Q4 2023 | $33.0M | 70.5% | $-32.3M | $-57.4M | $-9.15 | — |
| FY 2023 | $152.1M | 82.2% | $-243.5M | $-331.9M | $-70.05 | — |